Default: Leukemia Research

ISSN: 0145-2126

Journal Home

Journal Guideline

Leukemia Research Q2 Unclaimed

Elsevier Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Leukemia Research is a journal indexed in SJR in Hematology and Oncology with an H index of 96. It has an SJR impact factor of 0,694 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,694.

Leukemia Research focuses its scope in these topics and keywords: leukemia, induces, myeloid, monoclonal, antibody, apoptosis, inhibition, patients, chronic, tcells, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Leukemia Research

0,694

SJR Impact factor

96

H Index

123

Total Docs (Last Year)

405

Total Docs (3 years)

3859

Total Refs

707

Total Cites (3 years)

281

Citable Docs (3 years)

1.61

Cites/Doc (2 years)

31.37

Ref/Doc

Comments

No comments ... Be the first to comment!

Other journals with similar parameters


Cytokine: X Q2
Cytokine Q2
Hematological Oncology Q2
Platelets Q2
Stem Cells and Development Q2

Compare this journals

Aims and Scope


leukemia, induces, myeloid, monoclonal, antibody, apoptosis, inhibition, patients, chronic, tcells, anticd, cells, band, chinese, dependant, diagnosis, children, chemotherapy, differentiating, arrest, bearing, cell, celllike, cellslongitudinal, cellsretrospective, cellsthe, characteristicsdasatinib,



Best articles by citations

Younger age observation IN myelodysplastic syndrome

View more

Translocation (8;21) in acute myeloid leukemia: When to treat? That is the question!!

View more

p53 overexpression in bone marrow biopsies in refractory anemia and aplastic anemia: impact of antibody selection

View more

Sezary cells with hairy projections

View more

121 Myelodysplastic syndrome and 17P deletion

View more

A comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations

View more

76 The absolute number of CD34+ cells and CD34+ cells in S-phase increase during the evolution of myelodysplastic syndromes (MDS)

View more

125 Clonal karyotypic abnormalities after autologous transplantation (AT)

View more

163 Amifostine in low-risk and combined therapy with gemcitabine in high-risk myelodysplastic syndromes

View more

50 Correlation of karyotype with clinical features and prognosis in 349 patients with MDS

View more

127 Both inhaled and ingested substances are involved in secondary myelodysplastic syndromes (MDS) with 6p changes

View more

128 Single del(11q) in a patient with RAEB which progressed to erythroleukemia

View more
SHOW MORE ARTICLES

169 Aggressive chemotherapy in MDS: The Dusseldorf experience

View more

26 Cytoplasmic abnormalities of erythroblasts in a patient with refractory anaemia with ring sideroblasts

View more

8 The history of MDS: The role of the F.A.B. classification and the development of risk assessment

View more

Deletion of parental GST genes as a possible susceptibility factor in the etiology of infant leukemia

View more

Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: a case-control study in Uruguay

View more

KRN5500 induces apoptosis (PCD) of myeloid leukemia cell lines and patient blasts

View more

The MRD1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes

View more

Autocrine and possible intracrine regulation of HL-60 cell proliferation by macrophage colony-stimulating factor

View more

45 Myelodysplastic syndrome in its fibrotic variant: A borderline to chronic myeloproliferation

View more

Successful management and perinatal outcome of pregnancy complicated with myelodysplastic syndrome

View more

Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines

View more

132 A case of a t(1;3)(p36:q21) in chronic myelomonocytic leukemia with thrombocytosis and TPO gene expression in malignant cells

View more

FAQS